Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Bril

Showing results (11-20 of 337) with videos related to

Pageof 34
Sort By:
Frontiers in Neurology|August 21, 2023
FcRN receptor antagonists in the management of myasthenia gravisVinaya Bhandari, Vera Bril
Pharmacology & Therapeutics|July 3, 2026
Nipocalimab and other FcRn blockers in neuromuscular disordersMohamed Khateb, Vera Bril
Transfusion Medicine Reviews|October 17, 2022
Therapies in Autoimmune Peripheral Neuropathies beyond Intravenous Immunoglobulin, Plasma Exchange and Corticosteroids: An Analytical ReviewAjith Sivadasan, Vera Bril
Nature Reviews. Neurology|March 24, 2020
New insights into very-late-onset myasthenia gravisCarolina Barnett, Vera Bril
Neurology|August 28, 2002
Comparison of sensory testing on different toe surfaces: implications for neuropathy screeningDimitri Dimitrakoudis, Vera Bril
Immunotherapy|April 25, 2025
Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospectsAlexandria Matic, Vera Bril
Plos One|May 22, 2024
Electrophysiological grading scale for polyneuropathy severityAlon Abraham, Vera Bril
Diabetes Care|October 29, 2002
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathyVera Bril, Bruce A Perkins
Continuum (Minneapolis, Minn.)|October 10, 2014
Acquired immune axonal neuropathiesVera Bril, Hans D Katzberg
Journal of the Neurological Sciences|June 14, 2025
Response to letter from zi yin YaoVera Bril, Nils Erik Gilhus
Pageof 34

Showing results (11-20 of 337) with videos related to

Sort By:
Pageof 34
Frontiers in Neurology|August 21, 2023
FcRN receptor antagonists in the management of myasthenia gravisVinaya Bhandari, Vera Bril
Pharmacology & Therapeutics|July 3, 2026
Nipocalimab and other FcRn blockers in neuromuscular disordersMohamed Khateb, Vera Bril
Transfusion Medicine Reviews|October 17, 2022
Therapies in Autoimmune Peripheral Neuropathies beyond Intravenous Immunoglobulin, Plasma Exchange and Corticosteroids: An Analytical ReviewAjith Sivadasan, Vera Bril
Nature Reviews. Neurology|March 24, 2020
New insights into very-late-onset myasthenia gravisCarolina Barnett, Vera Bril
Neurology|August 28, 2002
Comparison of sensory testing on different toe surfaces: implications for neuropathy screeningDimitri Dimitrakoudis, Vera Bril
Immunotherapy|April 25, 2025
Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospectsAlexandria Matic, Vera Bril
Plos One|May 22, 2024
Electrophysiological grading scale for polyneuropathy severityAlon Abraham, Vera Bril
Diabetes Care|October 29, 2002
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathyVera Bril, Bruce A Perkins
Continuum (Minneapolis, Minn.)|October 10, 2014
Acquired immune axonal neuropathiesVera Bril, Hans D Katzberg
Journal of the Neurological Sciences|June 14, 2025
Response to letter from zi yin YaoVera Bril, Nils Erik Gilhus
Pageof 34